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Bovine leukemia virus (BLV) proviral latency represents a
viral strategy to escape the host immune system and allow
tumor development. Besides the previously demonstrated
role of histone deacetylation in the epigenetic repression
of BLV expression, we showed here that BLV promoter
activity was induced by several DNA methylation inhibi-
tors (such as 5-aza-2’-deoxycytidine) and that overex-
pressed DNMT1 and DNMT3A, but not DNMT3B,
down-regulated BLV promoter activity. Importantly, cyto-
sine hypermethylation in the 5’-long terminal repeat
(LTR) U3 and R regions was associated with true latency
in the lymphoma-derived B-cell line L267 but not with
defective latency in YR2 cells. Moreover, the virus-
encoded transactivator Tax(BLV) decreased DNA methyl-
transferase expression levels, which could explain the
lower level of cytosine methylation observed in the L267
(LTaxSN) 5’-LTR compared with the L267 5’-LTR. Inter-
estingly, DNA methylation inhibitors and Tax(BLV) syner-
gistically activated BLV promoter transcriptional activity
in a cAMP-responsive element (CRE)-dependent manner.
Mechanistically, methylation at the -154 or -129 CpG
position (relative to the transcription start site) impaired
in vitro binding of CRE-binding protein (CREB) transcrip-
tion factors to their respective CRE sites. Methylation at
-129 CpG alone was sufficient to decrease BLV promoter-
driven reporter gene expression by 2-fold. We demon-
strated in vivo the recruitment of CREB/CRE modulator
(CREM) and to a lesser extent activating transcription fac-
tor-1 (ATF-1) to the hypomethylated CRE region of the
YR2 5’-LTR, whereas we detected no CREB/CREM/ATF
recruitment to the hypermethylated corresponding region
in the L267 cells. Altogether, these findings suggest that
site-specific DNA methylation of the BLV promoter
represses viral transcription by directly inhibiting tran-
scription factor binding, thereby contributing to true pro-
viral latency.
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